Wonderful science, sunny city, fantastic food!
Big news for our lab!
Big news! I am thrilled to share that my team has been selected to join the Collaborative Research Network (CRN), powered by Aligning Science Across Parkinson’s (ASAP), in partnership with The Michael J. Fox Foundation for Parkinson’s Research (MJFF).
Together, this network is working to map the biological blueprint of Parkinson’s disease and accelerate the path to new treatments.
Over the next three years, our team will be investigating how RNA damage and ribosomal dysfunction contribute to dopamine neuron vulnerability in Parkinson’s disease, with the goal of identifying early mechanisms that may open new therapeutic windows.
Explore all CRN teams at asapcrn.org and our project https://www.asapcrn.org/research-community/teams/parisiadou/
Wonderful news for the Parisiadou Lab: A new NINDS R01 award to support our Parkinson's Disease research!
We were just awarded an NIH NINDS grant to study the molecular pathophysiology of Parkinson’s disease. Time to celebrate!!!
Loukia 's work was featured at Northwestern Feinberg Breakthroughs!
A big thank you to the people who believed in me and trusted me when it mattered the most! Also, a big thank you to my trainees, from whom I learned a lot!
https://www.feinberg.northwestern.edu/research/about/newsletter/2026/04/bt-faculty-profile.html
Northwestern news center highlights a just published JCI study co-authored by Loukia
https://news.feinberg.northwestern.edu/2026/03/16/fda-approved-compound-promotes-neuroprotective-effects-in-parkinsons-disease/
Proud PI moment :)
Chuyu was named an open science champion by ASAP. She did an outstanding job incorporating open science practices into our new preprint. It is exciting to see such a strong commitment to transparent, rigorous, and accessible research from your trainees.
Our beautiful review about the role of LRRK2 at the synapse is out. It was back in 2009 when we first showed a role of LRRK2 at the synapse. We have learned so much more since then!
https://portlandpress.com/biochemj/article/482/21/BCJ20253351/236671/LRRK2-and-the-fragile-synapse-a-molecular-prelude
Our new preprint is out!
A new preprint on how LRRK2 deregulates the most vulnerable dopamine neuron subtypes in Parkinson's disease. I am incredible thrilled about this work, as it reflects the seamless collaboration among various labs, each bringing their unique expertise—just as science should advance.
https://www.biorxiv.org/content/10.1101/2025.08.28.672006v1.full.pdf
Loukia is presenting a seminar at the Biomedical Sciences Research Center in the southern suburbs of Athens. The center's advantageous proximity to the sea adds a beautiful backdrop.
PROUD PI moment
Chris Nasios, our research technician, is officially a medical student at Duke University School of Medicine. Way to go Chris!!